These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34596623)

  • 1. Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income Countries.
    Watson G; Dodd C; Munoz FM; Eckert LO; Jones CE; Buttery JP; Yildirim IB; Kachikis A; Heath PT; Schlaudecker EP; Bond NH; Santarcangelo PL; Wilcox CR; Bellamy K; Elmontser M; Sienas L; Simon R; Khalil A; Townsend R; Sturkenboom M; Black S
    Pediatr Infect Dis J; 2021 Dec; 40(12):1127-1134. PubMed ID: 34596623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHO global vaccine safety multi-country collaboration project on safety in pregnancy: Assessing the level of diagnostic certainty using standardized case definitions for perinatal and neonatal outcomes and maternal immunization.
    Stuurman AL; Sharan A; Jahagirdar S; Elango V; Riera-Montes M; Kashyap N; Biccler J; Poluru R; Arora N; Mathai M; Mangtani P; DeVlieger H; Anderson S; Whitaker B; Wong HL; Cutland C; Guillard Maure C;
    Vaccine X; 2021 Dec; 9():100123. PubMed ID: 34825164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstetric and neonatal outcomes in South Africa.
    Cutland CL; Sawry S; Fairlie L; Barnabas S; Frajzyngier V; Roux JL; Izu A; Kekane-Mochwari KE; Vika C; De Jager J; Munson S; Jongihlati B; Stark JH; Absalon J
    Vaccine; 2024 Feb; 42(6):1352-1362. PubMed ID: 38310014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the feasibility of passive surveillance for maternal immunization safety utilizing archival medical records in Kinshasa, Democratic Republic of the Congo.
    Gadoth A; Mukadi Nkamba D; Arena PJ; Hoff NA; Dzogang C; Kampilu D; Beya M; Wong HL; Anderson SA; Kaba D; Rimoin AW
    Vaccine; 2022 Jun; 40(26):3605-3613. PubMed ID: 35570074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization in pregnancy safety surveillance in low and middle-income countries- field performance and validation of novel case definitions.
    Kochhar S; Clarke E; Izu A; Emmanuel Kekane-Mochwari K; Cutland CL
    Vaccine; 2019 May; 37(22):2967-2974. PubMed ID: 31014963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: A feasibility assessment.
    Stuurman AL; Riera M; Lamprianou S; Perez-Vilar S; Anderson SA; Mangtani P; Devlieger H; Verstraeten T; Zuber PLF; Guillard Maure C
    Vaccine; 2018 Oct; 36(45):6736-6743. PubMed ID: 30266486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of adverse pregnancy and birth outcomes using archival medical records before and during the first wave of the COVID-19 pandemic in Kinshasa, Democratic Republic of Congo: a facility-based, retrospective cohort study.
    Arena PJ; Dzogang C; Gadoth A; Nkamba DM; Hoff NA; Kampilu D; Beia M; Wong HL; Anderson SA; Kaba D; Rimoin AW
    BMC Pregnancy Childbirth; 2023 Jan; 23(1):31. PubMed ID: 36647021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine safety surveillance in Kenya using GAIA standards: A feasibility assessment of existing national and subnational research and program systems.
    Izulla P; Wagai JN; Akelo V; Ombeva A; Okeri E; Onyango D; Omore R; Fuller S; Khagayi S; Were J; Anderson SA; Wong HL; Tippett Barr BA
    Vaccine; 2023 Sep; 41(39):5722-5729. PubMed ID: 37550143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Measurement of Perinatal and Neonatal Morbidity Characteristics and Applicability of GAIA Case Definitions: Results and Lessons Learnt of a Hospital-Based Prospective Cohort Study in the Valencia Region (2019-2020).
    Carmona A; Latorre Tejerina M; Martínez Sebastián A; Dobreva D; Jurca CP; Huerta Barberá S; Bernat Montoya V; Aristoy Zabaleta M; Pineda Caplliure A; Mansilla Roig B; Navío Anaya M; Tosca-Segura R; Tortajada-Girbés M; Díez-Domingo J; Orrico-Sánchez A
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine.
    Griffin JB; Yu L; Watson D; Turner N; Walls T; Howe AS; Jiang Y; Petousis-Harris H
    Vaccine; 2018 Aug; 36(34):5173-5179. PubMed ID: 30031662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing feasibility of resources at health facilities in Uganda to diagnose pregnancy and neonatal outcomes.
    Stark JH; Wool E; Tran L; Robinson E; Chemelski M; Weibel D; Huang WT; Kochhar S; Hardy JR; Bailey S; Galiwango E; Kajungu D
    Int Health; 2019 Mar; 11(2):128-135. PubMed ID: 30252056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardizing case definitions for monitoring the safety of maternal vaccines globally: GAIA definitions, a review of progress to date.
    Davies HG; Bowman C; Watson G; Dodd C; Jones CE; Munoz FM; Heath PT; Cutland CL; Le Doare K
    Int J Gynaecol Obstet; 2023 Jul; 162(1):29-38. PubMed ID: 37194339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome-based comparison of SMFM and ISUOG definitions of fetal growth restriction.
    Roeckner JT; Pressman K; Odibo L; Duncan JR; Odibo AO
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):925-930. PubMed ID: 33798274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.
    Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J
    Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Alabama Preterm Birth Study: diffuse decidual leukocytoclastic necrosis of the decidua basalis, a placental lesion associated with preeclampsia, indicated preterm birth and decreased fetal growth.
    Goldenberg RL; Faye-Petersen O; Andrews WW; Goepfert AR; Cliver SP; Hauth JC
    J Matern Fetal Neonatal Med; 2007 May; 20(5):391-5. PubMed ID: 17674243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of customization and use of a fetal growth standard on the association between birthweight percentile and adverse perinatal outcome.
    Sovio U; Smith GCS
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S738-S744. PubMed ID: 29199029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse maternal and neonatal outcomes among women with preeclampsia with severe features <34 weeks gestation with versus without comorbidity.
    Venkatesh KK; Strauss RA; Westreich DJ; Thorp JM; Stamilio DM; Grantz KL
    Pregnancy Hypertens; 2020 Apr; 20():75-82. PubMed ID: 32193149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
    Boutin A; Guerby P; Gasse C; Tapp S; Bujold E
    Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review.
    Davies HG; Thorley EV; Al-Bahadili R; Sutton N; Burt J; Hookham L; Karampatsas K; Lambach P; Muñoz F; Cutland CL; Omer S; Le Doare K
    Vaccine X; 2024 Jun; 18():100464. PubMed ID: 38495929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.
    Vergnano S; Buttery J; Cailes B; Chandrasekaran R; Chiappini E; Clark E; Cutland C; de Andrade SD; Esteves-Jaramillo A; Guinazu JR; Jones C; Kampmann B; King J; Kochhar S; Macdonald N; Mangili A; de Menezes Martins R; Velasco Muñoz C; Padula M; Muñoz FM; Oleske J; Sanicas M; Schlaudecker E; Spiegel H; Subelj M; Sukumaran L; Tagbo BN; Top KA; Tran D; Heath PT;
    Vaccine; 2016 Dec; 34(49):6038-6046. PubMed ID: 27491687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.